STAT

STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation

STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammationWorldPing

Novo Nordisk has stopped two trials of a drug that aims to tame inflammation as a way to improve cardiovascular health, another blow for the approach.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

More coverage: all health news on WorldPing.

Related news